Search

SGX-523

A MET receptor tyrosine kinase inhibitor.

Hydrocortisone aceponate

Ergometrine

An ergot alkaloid with uterine and vascular smooth muscle contractile properties.

Angiotensin II

The novelty of the medication lies in the fact that it is the first and only use of synthetic human angiotensin II to help maintain body blood pressure.

Pucotenlimab

It received its first global approval in China in July 2022 for the treatment of solid tumours.[A257296] It is being investigated in other cancers.

Cilnidipine

It was jointly developed by Fuji Viscera Pharmaceutical Company, Japan and Ajinomoto, Japan and approved in 1995.

Iophendylate

It next appeared on the world scene for high volume (12-15cc), routine use, in diagnosing disc herniations. A number of clinicians have published on the dangers of oil myelography. … In 1942 Van Wagenen (a neurosurgical colleague of Warrens, at the University of Rochester) identified Iophendylate as causing chemical meningitis in 30 patients where "space-displacing masses within the

Seproxetine

It is a selective serotonin reuptake inhibitor (SSRI). It is an active metabolite of fluoxetine.

Ifenprodil

[A220133] Further studies elucidated that ifenprodil binds strongly at the inter-subunit interface of adjacent GluN1 and GluN2B NTDs, where it acts as a non-competitive antagonist. … In addition, allosteric modulators are known to bind at the NTDs and form another layer of regulation.

Dextroamphetamine

Dextroamphetamine is the dextrorotatory enantiomer of amphetamine . Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder.